This compound is primarily utilized in the development of antibody-drug conjugates (ADCs), which are targeted cancer therapies. It functions as a potent cytotoxic agent, designed to be linked to monoclonal antibodies that specifically recognize and bind to cancer cells. Once the conjugate is internalized by the cancer cell, the compound is released, leading to cell death by disrupting microtubule dynamics, which is essential for cell division and survival. Its high potency makes it particularly effective in treating cancers that are resistant to conventional therapies, offering a promising approach for precision medicine in oncology.